Advanced search
Publication Cover
Future Oncology Volume 12, 2016 - Issue 23
Submit an article Journal homepage
787
Views
0
CrossRef citations to date
0
Altmetric
Conference Report

Advances in Brain Metastases Presented at the American Society of Clinical Oncology 2016 Annual Meeting: Part II

Lucy F Chen1 Section of Hematology & Oncology, University of Illinois at Chicago, Chicago, IL, USACorrespondence[email protected]
,
Jyoti D Patel2 Section of Hematology & Oncology, University of Chicago, Chicago, IL, USA
&
Rimas V Lukas3 Department of Neurology, University of Chicago, Chicago, IL, USA
Pages 2669-2672 | Received 12 Aug 2015, Accepted 23 Aug 2016, Published online: 08 Sep 2016

References

  • Kayama T , SatoS, SakuradaKet al. JCOG0504: a Phase III randomized trial of surgery with whole brain radiation therapy versus surgery with salvage stereotactic radiosurgery in patients with 1 to 4 brain metastases. J. Clin. Oncol.34(Suppl.), Abstract 2003 (2016).
  • Prabhu RS , PressRH, PatelKRet al. Single fraction stereotactic radiosurgery (SRS) alone versus surgical resection and SRS boost for large brain metastases: a multi-institutional analysis. J. Clin. Oncol.34(Suppl.), Abstract 2076 (2016).
  • Abouharb S , EnsorJ, LoghinMEet al. Leptomeningeal disease and breast cancer: the importance of tumor subtype. Breast Cancer Res. Treat.146(3), 477–486 (2014).
  • De Avevedo C , CruzMR, ChinenLTet al. Meningeal carcinomatosis in breast cancer: prognostic factors and outcome. J. Neurooncol.104, 565–572 (2011).
  • Kumthekar P , TangSC, BrennerAJet al. ANG1005, a novel brain-penetrant taxane derivative, for the treatment of recurrent brain metastases and leptomeningeal carcinomatosis from breast cancer. J. Clin. Oncol.34(Suppl.), Abstract 2004 (2016).
  • Eichler AF , KahlerKT, WangDLet al. EGFR mutation status and survival after diagnosis of brain metastasis in nonsmall cell lung cancer. Neuro Oncol.12(11), 1193–1199 (2010).
  • Ahn MJ , KimDW, KimTMet al. Phase I study of AZD3759, a CNS penetrable EGFR inhibitor, for the treatment of non-small-cell lung cancer (NSCLC) with brain metastasis (BM) and leptomeningeal metastasis (LM). J. Clin. Oncol.34(Suppl.), Abstract 9003 (2016).
  • Yang JC , KimDW, KimSWet al. Osimertinib activity in patients (pts) with leptomeningeal (LM) disease from non-small cell lung cancer (NSCLC): updated results from BLOOM, a Phase I study. J. Clin. Oncol.34(Suppl.), Abstract 9002 (2016).
  • Dudani S , MazzarelloS, HiltonJFet al. Optimal management of leptomeningeal carcinomatosis in breast cancer patients – a systematic review. J. Clin. Oncol.34(Suppl.), Abstract e13526 (2016).
  • Robert C , SchachterJ, LongGet al. Pembrolizumab versus ipilimumab in advanced melanoma. N. Engl. J. Med.372, 2521–2532 (2015).
  • Dagogo-Jack I , Hurder-GiobbieA, GainorJFet al. Retrospective analysis of activity of pembrolizumab (pembro) in melanoma patients (pts) with brain metastasis (BM). J. Clin. Oncol.34(Suppl.), Abstract 2071 (2016).
  • Kluger HM , GoldbergSB, SznolMet al. Safety and activity of pembrolizumab in melanoma patients with untreated brain metastases. J. Clin. Oncol.33(Suppl.), Abstract 9009 (2015).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.